Molecular Diagnosis & Therapy

Papers
(The TQCC of Molecular Diagnosis & Therapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker143
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review85
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects62
Marnetegragene Autotemcel: First Approval61
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”60
Considering Tumour Sidedness is Critical for Accurate Interpretation of Liquid Biopsy Results in Metastatic Colorectal Cancer43
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target43
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate43
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors41
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights40
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma37
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?35
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models35
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach34
The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs34
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors32
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk30
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders27
Correction to: Revakinagene Taroretcel: First Approval27
Personalizing Oncolytic Immunovirotherapy Approaches26
Fatty Acid Desaturase: The Yin or Yang of Disease Pathology26
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics25
Advances and Challenges in the Diagnosis of Leishmaniasis25
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease24
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics23
Afamitresgene Autoleucel: First Approval23
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges22
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”21
Long-Range PCR and Nanopore Sequencing Enables High-Throughput Detection of TCF4 Trinucleotide Repeat Expansions in Fuchs Endothelial Corneal Dystrophy21
Molecular Therapeutics in Development to Treat Alzheimer’s Disease20
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study20
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy20
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer19
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants19
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations19
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies18
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer17
The Emerging Role of Olfactory Receptors: From Genomics to Precision Medicine17
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia17
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort17
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?16
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis16
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease15
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors15
Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions15
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis15
Lifileucel: First Approval15
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation15
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders15
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings14
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”14
Cytokines at the Crossroads of Mitochondrial Dysfunction and Inflammation in Colorectal Cancer: Implications for Postoperative Complications14
Cell-Free HPV-DNA in Screening, Diagnosis, Prognosis, and Treatment Response Monitoring of Cervical Cancer14
The Role οf Ion Channels in the Development and Progression of Prostate Cancer14
Diagnostic Performance of the ASCL1/ZNF582 Methylation Test for Detection of High-Grade Vulvar Intraepithelial Neoplasia and Vulvar Cancer14
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma13
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R13
Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer13
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma12
Multiplex RT-PCR-Based Sequencing Assay to Detect Kidney Cancer-Specific Splice Variants in Tumor Tissues and Plasma Cell-Free RNAs12
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting12
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models12
Obecabtagene Autoleucel: First Approval12
Emerging RNAi Therapies to Treat Hypertension12
Future Prospects for Epigenetics in Autism Spectrum Disorder11
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis11
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab11
Blood Biomarkers of Long COVID: A Systematic Review11
Retroviral Remnants in the Human Genome: Classification, Integration and Regulation11
Inner Ear Gene Therapy: An Overview from Bench to Bedside11
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”11
0.10123515129089